Innovation & Technology transfer

Four companies have been created since launch of the program.

Resilience : a mobile application to better manage the disease.

ORAKL : development of functional in vitro diagnostic tests, “organograms”, to predict the responses of cancers to drugs.

Cure51 : learning from cancer survivors

Elikya Therapeutics : innovative molecules for cancer treatment.

 Prism is a one-of-a kind partnership between


Centre National de Médecine de Précision en Oncologie

Where to find us

Prism  IHU-B

Bâtiment de médecine moléculaire

32 Rue Camille Desmoulins

94800 Villejuif

Tél. +33(0)1 42 11 00 00

info -at-



Work with us

Call for project



Legal notice

Connect with us